Printer Friendly

BRISTOL-MYERS SQUIBB SHARE PURCHASE PROGRAM INCREASED

 NEW YORK, April 6 /PRNewswire/ -- The board of directors of Bristol- Myers Squibb Company (NYSE: BMY) today increased the authorization under the company's current share purchase program from 25 million shares to 50 million shares.
 Richard L. Gelb, chairman and chief executive officer, stated that, "Current market conditions have created an excellent opportunity to strengthen the company through a purchase of a portion of its own shares."
 The shares will be purchased from time to time in the open market or through private transactions. The stock purchased under the program will be available for use under the company's employee benefit programs, for conversion of the company's preferred stock and for general corporate purposes.
 The previous authorization was approved by the board of directors in October 1987. To date, 21.2 million shares have been purchased under the program.
 -0- 4/6/93
 /CONTACT: Anthony Carter of Bristol-Myers Squibb Company, 212-546-4339/
 (BMY)


CO: Bristol-Myers Squibb Company ST: New York IN: MTC SU:

TS -- NY059 -- 3561 04/06/93 16:32 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 6, 1993
Words:170
Previous Article:/C O R R E C T I O N -- LASERTECHNICS, INC./
Next Article:UNITED AIRLINES MARCH TRAFFIC INCREASES 17.4 PERCENT
Topics:


Related Articles
BRISTOL-MYERS SQUIBB ANNOUNCES VOLUNTARY REDUCTION IN PHARMACEUTICAL PRICES TO FEDERAL GOVERNMENT
BRISTOL-MYERS SQUIBB ANNOUNCES VOLUNTARY REDUCTION IN PHARMACEUTICAL PRICES TO FEDERAL GOVERNMENT
BRISTOL-MYERS SQUIBB COMPANY CREATESINNOVATIVE SALES CONSULTANT PROGRAM
BRISTOL-MYERS SQUIBB PROPOSES ACQUISITION OF RESEARCH-BASED FRENCH PHARMACEUTICAL FIRM
BRISTOL-MYERS SQUIBB SUPPORTS NATIONAL CANCER ORGANIZATION AND TOP FEMALE VOCALISTS TO ENCOURAGE BREAST HEALTH AWARENESS
BRISTOL-MYERS SQUIBB INVESTS IN SOMATIX; COMPANIES TO EVALUATE POSSIBLE AREAS FOR COLLABORATION IN GENE THERAPY
BRISTOL-MYERS SQUIBB AND SIBIA ANNOUNCE RESEARCH COLLABORATION; AGREEMENT TO DEVELOP DRUGS TO TREAT ALZHEIMER'S DISEASE
BRISTOL-MYERS SQUIBB TO ACQUIRE HUNGARIAN HEALTH CARE COMPANY
BOARD OF BRISTOL-MYERS SQUIBB AUTHORIZES INCREASE IN SHARE REPURCHASE PROGRAM
Bristol-Myers Squibb Increases Dividend

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters